PTGX Stock-Based Compensation
Protagonist Therapeutics Inc · Stock-Based Compensation
PTGX Stock-Based Compensation
Latest reported$49.82Mperiod ending
PTGX Stock-Based Comp ($42.00K → $49.82M)
Annual stock-based compensation
High-resolution chart · PNG
PTGX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 45,974,000 | |
| 37,554,000 | |
| 29,293,000 | |
| 24,202,000 | |
| 16,395,000 | |
| 7,899,000 | |
| 8,353,000 | |
| 6,919,000 | |
| 4,241,000 | |
| 2,130,000 | |
| 99,000 | |
| 42,000 |